Atazanavir for HIV Infected Individuals: An Early Access Program
Status:
No longer available
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to provide atazanavir to patients infected
with human immunodeficiency virus (HIV) whose antiviral medications are no longer working to
control HIV activity within the body and who are unable to create a new treatment regimen
using other available anti-HIV drugs, because of either side effects or treatment failure
previously taken. The safety of this treatment will also be studied.